Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionWaldron Private Wealth LLC
Latest Disclosed Ownership12,580 shares
Latest Disclosed Value $ 762,978
Waldron Private Wealth LLC reports 6.66% increase in ownership of BMY / Bristol-Myers Squibb Company

On April 10, 2026 - Waldron Private Wealth LLC filed a 13F-HR form disclosing ownership of 12,580 shares of Bristol-Myers Squibb Company (US:BMY) valued at $762,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 11,795 shares of Bristol-Myers Squibb Company. This represents a change in shares of 6.66% during the quarter. The current value of the position is $688,378 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,580 785 6.66 763 19.81 0.0298
2026-01-14 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 11,795 -148 -1.24 636 18.22 0.0251
2025-10-30 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,943 0 0.00 539 -2.54 0.0218
2025-07-31 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,943 -412 -3.33 553 -26.69 0.0241
2025-05-08 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,355 -16,143 -56.65 754 -53.26 0.0356
2025-01-24 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 28,498 15,770 123.90 1,612 144.83 0.0649
2024-10-21 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,728 -998 -7.27 659 15.44 0.0273
2024-07-31 2024-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 13,726 159 1.17 570 -22.45 0.0255
2024-05-09 2024-03-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 13,567 -284 -2.05 736 3.52 0.0332
2024-08-29 2023-12-31 13F/A-1 BRISTOL-MYERS SQUIBB CO COM COM 110122108 13,851 -3,995 -22.39 711 -31.40 0.0338
2024-01-30 2023-12-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 13,851 -3,995 1 0.0338
2024-08-29 2023-09-30 13F/A-1 BRISTOL-MYERS SQUIBB CO COM COM 110122108 17,846 3,032 20.47 1,036 9.29 0.0538
2023-10-26 2023-09-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 17,846 3,032 1 0.0537
2024-08-29 2023-06-30 13F/A-1 BRISTOL-MYERS SQUIBB CO COM COM 110122108 14,814 -8,107 -35.37 947 -40.37 0.0473
2023-08-07 2023-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 14,814 -8,107 1 0.0473
2024-08-29 2023-03-31 13F/A-1 BRISTOL-MYERS SQUIBB CO COM COM 110122108 22,921 3,405 17.45 1,589 158,700.00 0.0773
2023-05-02 2023-03-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 22,921 3,405 2 0.0773
2023-02-08 2022-12-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 19,516 0 0.00 1 -99.93 0.0862
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 19,516 146 0.75 1,387 -6.98 0.0862
2022-08-03 2022-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 19,370 1,449 8.09 1,491 13.99 0.0836
2022-05-04 2022-03-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 17,921 1,074 6.38 1,308 24.57 0.0671
2022-02-02 2021-12-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 16,847 -1,624 -8.79 1,050 -3.85 0.0518
2021-11-02 2021-09-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 18,471 -1,210 -6.15 1,092 -16.96 0.0635
2021-08-06 2021-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 19,681 5,958 43.42 1,315 51.85 0.0840
2021-05-11 2021-03-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 13,723 -836 -5.74 866 -4.10 0.0602
2021-02-12 2020-12-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 14,559 -540 -3.58 903 -0.77 0.0672
2020-11-13 2020-09-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 15,099 -135 -0.89 910 1.68 0.0778
2020-08-11 2020-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 15,234 -4,448 -22.60 895 -18.41 0.0791
2020-05-05 2020-03-31 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 19,682 6,272 46.77 1,097 27.56 0.1169
2020-02-07 2019-12-31 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 13,410 6,586 96.51 860 148.55 0.0766
2019-11-06 2019-09-30 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 6,824 69 1.02 346 13.07 0.0352
2019-07-31 2019-06-30 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 6,755 -537 -7.36 306 -11.82 0.0326
2019-05-01 2019-03-31 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 7,292 3,254 80.58 347 66.03 0.0391
2019-02-13 2018-12-31 13F Bristol Myers Squibb COM 110122108 4,038 4,038 209 0.0301
2018-08-09 2018-06-30 13F Bristol Myers Squibb COM 110122108 0 -3,493 -100.00 0 -100.00
2018-05-09 2018-03-31 13F Bristol Myers Squibb COM 110122108 3,493 -325 -8.51 220 -5.58 0.0495
2018-01-26 2017-12-31 13F Bristol Myers Squibb COM 110122108 3,818 0 0.00 233 -4.12 0.0548
2017-11-08 2017-09-30 13F Bristol Myers Squibb COM 110122108 3,818 3,818 243 0.0679
2017-08-14 2017-06-30 13F Bristol Myers Squibb COM 110122108 0 -8,749 -100.00 0 -100.00
2017-05-18 2017-03-31 13F/A-2 Bristol Myers Squibb COM 110122108 8,749 8,749 0.00 475 0.00 0.0764
2017-04-27 2017-03-31 13F/A-1 Bristol Myers Squibb COM 110122108 8,749 0 475 0.0710
2017-04-24 2017-03-31 13F Bristol Myers Squibb COM 110122108 8,749 475
2017-01-27 2016-12-31 13F Bristol Myers Squibb COM 110122108 0 -4,267 -100.00 0 -100.00
2016-11-14 2016-09-30 13F Bristol Myers Squibb COM 110122108 4,267 -166 -3.74 230 -29.45 0.0833
2016-08-11 2016-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 4,433 207 4.90 326 21.19 0.1198
2016-08-09 2016-06-30 13F Bristol Myers Squibb COM 110122108 4,065 240
2016-08-11 2016-03-31 13F/A-2 Bristol Myers Squibb COM 110122108 4,226 150 3.68 269 -3.93 0.1015
2016-08-09 2016-03-31 13F/A-1 Bristol Myers Squibb COM 110122108 4,076 -150 280 0.1044
2016-05-09 2016-03-31 13F Bristol Myers Squibb COM 110122108 4,065 240
2016-02-05 2015-12-31 13F Bristol Myers Squibb COM 110122108 4,076 11 0.27 280 16.67 0.1044
2015-11-13 2015-09-30 13F Bristol Myers Squibb COM 110122108 4,065 4,065 240 0.1036
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.